Avior Bio

About:

Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions.

Website: http://www.aviorbio.com/

Top Investors: National Science Foundation, North Carolina Biotechnology Center

Description:

Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions. Using its disruptive drug delivery technology – Speedit™ Transmucosal Film Technology – we are positioned to develop products that bring unsurpassed value in efficacy and safety. Avior has an excellent management team, a strong advisory board, supportive partners, dedicated scientists, and knowledgeable clinicians that position us to be successful.